Inhibrx Biosciences Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$60.92

-3.95 (-6.09%)

As of Mar 22, 10:10 PM ET ·

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target -70.2% upside

Low Target $12.39

Average Target $18.13

High Target $27.56

Current Price $60.92

Current
$60.92

Target
$18.13

$12.39 $18.13 avg $27.56

Scenario Analysis

Bear Case

$12.39

-79.7%

Low target

Base Case

$18.13

-70.2%

Avg target

Bull Case

$27.56

+-54.8%

High target

Risk/Reward

0.7x

Unfavorable

Price in Context

52-Week High

$94.57

-35.6% from high

52-Week Low

$10.81

+463.8% from low

Target vs 52W High

$18.13

-80.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%